Amodiaquine Failure and Glutathione in Malaria
Author Information
Author(s): Zuluaga Lina, Pabón Adriana, López Carlos, Ochoa Aleida, Blair Silvia
Primary Institution: Universidad de Antioquia
Hypothesis
Is there a relationship between glutathione production and the therapeutic response to amodiaquine in malaria patients?
Conclusion
The study suggests that differences in glutathione metabolism may explain therapeutic failure to amodiaquine in malaria patients.
Supporting Evidence
- Amodiaquine failure was found in 31.25% of patients.
- Lower total glutathione concentration was associated with therapeutic failure.
- Higher glutathione reductase activity was observed in parasitized erythrocytes compared to non-infected ones.
Takeaway
This study looked at how a substance called glutathione affects the success of a malaria treatment. It found that lower levels of glutathione might make the treatment less effective.
Methodology
The therapeutic response to amodiaquine was evaluated in 32 patients over 28 days, measuring glutathione levels and enzyme activities in different blood components.
Limitations
The study was limited by the small sample size and the inability to include more patients due to high therapeutic failure rates.
Participant Demographics
Mean age was 27 years, with 17 males and 15 females.
Statistical Information
P-Value
p < 0.02
Statistical Significance
p < 0.003
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website